Authors

Getting Started With Practice Tech: Pearls From Brandon Beal, MD

Brandon Beal, MD shared his experience, which technology solutions work best, and resources available to dermatology practices.

A New Role for Will Kirby, DO, FAOCD

How does a dermatologist go from the clinic to the television screen? Editorial Board member Will Kirby, DO, FAOCD, shares his thoughts about reality television and his appearance The Traitors.

Study Finds Disparities in Access to Patient Portals Despite a Rise in Use

The study found that white patients were offered access to patient portals more frequently than Black or Hispanic patients.

Improve Patient Outcomes With Better Language Access

Medical practices can choose from a wide array of tools to enable communication with patients from diverse backgrounds.

Mohs Micrographic Surgery in High-Profile Patients: A Call for Expanding Access to Skin Cancer Care

President Biden's Mohs surgery highlights the need for equitable access to this effective skin cancer treatment, emphasizing its benefits and ongoing disparities.

The Role of Pharmacists in Providing Patient Counseling On Topical Niacinamide For Acne and More

Niacinamide is a versatile skincare ingredient that effectively targets acne, age-related issues, hyperpigmentation, and atopic dermatitis, writes Anjeza Fero, PharmD, RPh.

Addressing Delays in Prior Authorization Processes That Negatively Impact Patients

John Barbieri, MD, MBA, discusses how deteriorating prior authorization processes are compromising access to essential dermatologic therapies.

Opening Doors of Communication: Social Media Trends and Challenges

Luke Maxfield, DO, discusses the importance of understanding social media trends and engaging patients in dialogues.

Omicron COVID-19 variant: What we know and what we don’t

The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.

Dermavant Moves One Step Closer to Potential New Treatment Option for Patients with Plaque Psoriasis

Derm Dispatch: SDPA President-Elect Andrew Baker, MBA, MPAS, PA-C, Shares His Vision

Andrew Baker, MBA, MPAS, PA-C, discusses leadership and inclusivity in dermatology at the SDPA Fall Conference, emphasizing collaboration and member engagement for future growth.

Nkem Ugonabo, MD, MPH, and Adelle Infante: Mentorship of Young Women and Girls in STEM, Dermatology

Allergan Aesthetics recently announced the fifth-year of its partnership with Girls Inc. Nkem Ugonabo, MD, MPH, and Adelle Infante recently spoke with Dermatology Times to discuss the importance of STEM and dermatology mentorship.

Higher Treatment, Health Care Costs Associated With Advanced Melanomas

Greater treatment costs are associated with more advanced stages of melanoma, particularly due to increasing prices of treatments.

Case Report: Repigmentation of the Lips Using Ruxolitinib

Dive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.

Cutiss, DenovoSkin Changing the Standard of Burn Care Across the Globe

CEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.

Upadacitinib Demonstrates Efficacy in Patients With AD and Head and Neck Involvement

Kilian Eyerich, MD, PhD, shares insights into an EADV 2024 presentation on upadacitinib’s ability to achieve almost total skin clearance in the head and neck regions with minimal effect on quality of life.

Additional Medicaid Expansion Would Provide Advantages to Patients With Melanoma

During the 2024 American Society of Clinical Oncology annual meeting, a poster highlighted the advantages Medicaid expansion could offer to individuals with melanoma.

Developing an OTC Dermatology Product

Renata Block, MMS, PA-C, and Erica Ramos, PA-C, discuss the complexities of developing an over-the-counter hair product.

Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.

Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS

Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.

FDA Allows First Biosimilar Without Clinical Efficacy Trials

The FDA's groundbreaking decision to waive clinical efficacy studies for a monoclonal antibody biosimilar revolutionizes drug approval, reducing costs and enhancing patient access.

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

Brauer’s textbook can be purchased through Amazon and Barnes & Noble.

Can Supplements Effectively Manage Hair Loss?

Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.

Insights Into Positive Decision for Galderma's RelabotulinumtoxinA in Europe

Sachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.

Striving for Melanoma Advancements With the Melanoma Research Alliance

Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.

What You Need to Know About Mentoring Doctors

Defining the goals of the mentoring relationship can be useful to clarify expectations.

Best Communication Practices to Explain Palliative Care Plans

Katie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.

Clascoterone cream 1% targets androgen receptors

The topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.

Tracee Blackburn, PA-C: Gut Health for Healthy Skin

Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.